Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2024 finan

By: financialpost.com

Oct 31 2024
0
0 Views

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299 Read More

Cenovus announces third quarter 2024 results

Li-Cycle and Glencore Establish Commercial Framework for Rochester Hub Products

Labour Taxes Risk Extending UK Wage Stagnation, Analysis Shows

Chinese western city Weinan becoming printing and packaging hub

Fires and Floods Turn Climate Into a Major Worry for Brazilians

As America Votes, These Big Energy Projects Hang in the Balance

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Vista Gold Phase 2 Drilling Continues to Intercept High Grade Gold Mineralized Intervals in the South Cross Lode at Mt Todd

AECOM selected for a $90 million single-award task order for the G7 Partnership for Global Infrastructure and Investment

Infobip recognized as RCS Business Messaging Leader by Juniper Research

Prairie Provident Announces Closing of Rights Offering

Pakistan Airlines Sale Gets One Bid From Real Estate Group

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Related